Moreover, key gene mutations, such as phosphatidylinositide 3-kinases catalytic subunit α (PIK3CA), Kirsten rat sarcoma viral oncogene homolog (KRAS), and epidermal growth factor receptor (EGFR), have been observed in cervical cancer patients.4 This evidence concerns the gene KRAS and cervical carcinoma.